CYP19A1 and metabolic syndrome: Men with mutations in the Cyp19 gene (which encodes aromatase) show lipid profiles similar to patients with metabolic syndrome including elevated triglyceride levels and low concentrations of high-density lipoproteins, indicative of fatty liver disease [55,56,57].